Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01067209 · ClinicalTrials.gov registry record
Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 18
- Enrollment target
NCT01067209: Completed study, sponsored by Washington University School of Medicine.
NCT01067209 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01067209 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate the effect of gastric bypass surgery-induced weight loss on the heart's function and on fat deposits in the heart muscle.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-02-14 |
What the finished NCT01067209 record still lists
NCT01067209 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01067209 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01067209 about?
NCT01067209 is a clinical study titled "Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery". The overall purpose of this study is to evaluate the effect of gastric bypass surgery-induced weight loss on the heart's function and on fat deposits in the heart muscle.
What is the current status of trial NCT01067209?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2010-01. Estimated completion is 2013-02-14.
Who is sponsoring clinical trial NCT01067209?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia